PTC Therapeutics | PTCT - Creditori Commerciali

Prezzo Delle Azioni
68.23
Cambio Giornaliero
-0.36 -0.52%
Mensile
2.22%
Annuale
37.75%
Q2 Previsione
66.77




Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Gilead Sciences USD 715M 93M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xencor USD 10.83M 1.75M 2025-12